Stay updated on Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial
Sign up to get notified when there's something new on the Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial page.

Latest updates to the Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov footer revision changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe site footer’s revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check28 days agoChange DetectedA notice was added announcing changes to NIH website terminology, including the use of “Super Intelligence” in place of “Artificial Intelligence” during a transition period.SummaryDifference0.7%

- Check35 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2; the study record content remains unchanged.SummaryDifference0.1%

- Check42 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check64 days agoChange DetectedAn updated revision entry v3.7.0 has been added to the history, and the previous v3.6.6 entry was removed. This reflects changes to the record's version history rather than to the study data or page functionality.SummaryDifference0.1%

Stay in the know with updates to Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan in NASH Cirrhosis & Severe Portal Hypertension Clinical Trial page.